Remote Monitoring in Patients With Coronavirus Disease (COVID-19)
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 主要终点
- Number of different arrhythmias
研究概览
简要总结
The objective of the study is to assess the impact of remote cardiac and vital sign monitoring in patients with coronavirus disease (COVID-19) in the outpatient setting.
详细描述
The objective of the study is to assess the impact of remote cardiac and vital sign monitoring in patients with coronavirus disease (COVID-19) in the outpatient setting. This study will enroll COVID-19 positive patients previously evaluated at Mount Sinai Hospital/Mount Sinai Health System (MSHS) and affiliated hospitals deemed appropriate for home monitoring. Patients will be monitored remotely in the outpatient setting for 1-3 weeks following diagnosis and/or treatment for COVID-19 at MSH/MSHS.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients diagnosed with coronavirus and determined to be eligible for home monitoring and self-care, and either
- •Not admitted to the hospital, and permitted to recover at home
- •Discharged from inpatient hospitalization, during the acute recovery period
- •18 years old or older with the ability to understand the requirements of the study and sign the informed consent form (or able to provide over-the-phone verbal consent).
排除标准
- 未提供
研究组 & 干预措施
Vital Connect Patch Arm
This is a non-randomized study. Based on clinical assessment, patients will be provided with the following home monitoring system:
VitalConnect Vital Sign Patch (FDA approved for this indication)
干预措施: VitalConnect Vital Sign Patch (Diagnostic Test)
结局指标
主要结局
Number of different arrhythmias
时间窗: 7-14 Days
ac rhythm in patients with COVID-19 infection following treatment/discharge from MSH
Temperature
时间窗: 7-14 Days
Temperature of patients with COVID-19 infection following treatment/discharge from MHS
Oxygen Saturation
时间窗: 7-14 Days
Oxygen saturation level in patients with COVID-19 infection following treatment/discharge from MSH
次要结局
未报告次要终点
研究者
Vivek Reddy
Professor
Icahn School of Medicine at Mount Sinai